Literature DB >> 23612037

Development and psychometric evaluation of a cardiovascular risk and disease management knowledge assessment tool.

James S Rosneck1, Joel Hughes, John Gunstad, Richard Josephson, Donald A Noe, Donna Waechter.   

Abstract

PURPOSE: This article describes the systematic construction and psychometric analysis of a knowledge assessment instrument for phase II cardiac rehabilitation (CR) patients measuring risk modification disease management knowledge and behavioral outcomes derived from national standards relevant to secondary prevention and management of cardiovascular disease.
METHODS: First, using adult curriculum based on disease-specific learning outcomes and competencies, a systematic test item development process was completed by clinical staff. Second, a panel of educational and clinical experts used an iterative process to identify test content domain and arrive at consensus in selecting items meeting criteria. Third, the resulting 31-question instrument, the Cardiac Knowledge Assessment Tool (CKAT), was piloted in CR patients to ensure use of application. Validity and reliability analyses were performed on 3638 adults before test administrations with additional focused analyses on 1999 individuals completing both pretreatment and posttreatment administrations within 6 months.
RESULTS: Evidence of CKAT content validity was substantiated, with 85% agreement among content experts. Evidence of construct validity was demonstrated via factor analysis identifying key underlying factors. Estimates of internal consistency, for example, Cronbach's α = .852 and Spearman-Brown split-half reliability = 0.817 on pretesting, support test reliability. Item analysis, using point biserial correlation, measured relationships between performance on single items and total score (P < .01). Analyses using item difficulty and item discrimination indices further verified item stability and validity of the CKAT.
CONCLUSIONS: A knowledge instrument specifically designed for an adult CR population was systematically developed and tested in a large representative patient population, satisfying psychometric parameters, including validity and reliability.

Entities:  

Mesh:

Year:  2014        PMID: 23612037      PMCID: PMC3795841          DOI: 10.1097/JCN.0b013e31828f0d01

Source DB:  PubMed          Journal:  J Cardiovasc Nurs        ISSN: 0889-4655            Impact factor:   2.083


  30 in total

1.  A meta-analysis of psychoeduational programs for coronary heart disease patients.

Authors:  E Dusseldorp; T van Elderen; S Maes; J Meulman; V Kraaij
Journal:  Health Psychol       Date:  1999-09       Impact factor: 4.267

2.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.

Authors:  Sidney C Smith; Jerilyn Allen; Steven N Blair; Robert O Bonow; Lawrence M Brass; Gregg C Fonarow; Scott M Grundy; Loren Hiratzka; Daniel Jones; Harlan M Krumholz; Lori Mosca; Richard C Pasternak; Thomas Pearson; Marc A Pfeffer; Kathryn A Taubert
Journal:  Circulation       Date:  2006-05-16       Impact factor: 29.690

3.  Bristol COPD Knowledge Questionnaire (BCKQ): testing what we teach patients about COPD.

Authors:  R White; P Walker; S Roberts; S Kalisky; P White
Journal:  Chron Respir Dis       Date:  2006       Impact factor: 2.444

4.  AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services endorsed by the American College of Chest Physicians, American College of Sports Medicine, American Physical Therapy Association, Canadian Association of Cardiac Rehabilitation, European Association for Cardiovascular Prevention and Rehabilitation, Inter-American Heart Foundation, National Association of Clinical Nurse Specialists, Preventive Cardiovascular Nurses Association, and the Society of Thoracic Surgeons.

Authors:  Randal J Thomas; Marjorie King; Karen Lui; Neil Oldridge; Ileana L Piña; John Spertus; Robert O Bonow; N A Mark Estes; David C Goff; Kathleen L Grady; Ann R Hiniker; Frederick A Masoudi; Martha J Radford; John S Rumsfeld; Gayle R Whitman
Journal:  J Am Coll Cardiol       Date:  2007-10-02       Impact factor: 24.094

Review 5.  Selection and use of content experts for instrument development.

Authors:  J S Grant; L L Davis
Journal:  Res Nurs Health       Date:  1997-06       Impact factor: 2.228

6.  Perceived learning needs of patients with coronary artery disease using a questionnaire assessment tool.

Authors:  M L Czar; M M Engler
Journal:  Heart Lung       Date:  1997 Mar-Apr       Impact factor: 2.210

7.  Coronary heart disease knowledge tool for women.

Authors:  Joanne L Thanavaro; Samer Thanavaro; Timothy Delicath
Journal:  J Am Acad Nurse Pract       Date:  2010-02

Review 8.  A review to examine the use of SF-36 in cardiac rehabilitation.

Authors:  Kimberley Brown
Journal:  Br J Nurs       Date:  2003 Aug 14-Sep 10

9.  The METER: a brief, self-administered measure of health literacy.

Authors:  Katherine A Rawson; John Gunstad; Joel Hughes; Mary Beth Spitznagel; Vanessa Potter; Donna Waechter; James Rosneck
Journal:  J Gen Intern Med       Date:  2009-11-03       Impact factor: 5.128

10.  The test of functional health literacy in adults: a new instrument for measuring patients' literacy skills.

Authors:  R M Parker; D W Baker; M V Williams; J R Nurss
Journal:  J Gen Intern Med       Date:  1995-10       Impact factor: 5.128

View more
  2 in total

1.  Stakeholder-Engaged Measure Development for Pediatric Obstructive Sleep-Disordered Breathing: The Obstructive Sleep-Disordered Breathing and Adenotonsillectomy Knowledge Scale for Parents.

Authors:  Anne R Links; David E Tunkel; Emily F Boss
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-01-01       Impact factor: 6.223

2.  Development and Psychometric Evaluation of the Cardiac Rehabilitation Adherence Tool (CRAT).

Authors:  Behzad Hamedani; Hooman Shahsavari; Sara Amaniyan; Christina Sieloff; Mojtaba Vaismoradi
Journal:  J Cardiovasc Dev Dis       Date:  2019-07-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.